Literature DB >> 26159536

Draft Genome Sequences of the Two Unrelated Macrolide-Resistant Corynebacterium argentoratense Strains CNM 463/05 and CNM 601/08, Isolated from Patients in the University Hospital of León, Spain.

Maria Isabel Fernández-Natal1, Francisco Soriano2, Alberto Acedo3, Marta Hernandez4, Andreas Tauch5, David Rodríguez-Lázaro1.   

Abstract

Corynebacterium argentoratense has been associated mainly with infections in the human respiratory tract. Genome sequencing of two unrelated clinical macrolide-resistant strains, CNM 463/05 and CNM 601/08, revealed the presence of the antibiotic resistance gene erm(X) allocated to a specific genomic region with 100% similarity to the widely distributed transposable element Tn5432.
Copyright © 2015 Fernández-Natal et al.

Entities:  

Year:  2015        PMID: 26159536      PMCID: PMC4498122          DOI: 10.1128/genomeA.00765-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Corynebacterium argentoratense is a nonlipophilic, urease and nitrate reductase-negative, fermentative corynebacterial species producing acid from glucose but not from maltose and sucrose (1). It was initially isolated from patients suffering tonsillitis in Strasbourg, France (2, 3). Since the first isolation of C. argentoratense, it has been obtained from the respiratory tract of humans (4), blood cultures (5, 6), intravenous sites (7), ear (4), and conjunctival fornix (8) and from adenoid tissues associated with otitis media (9). The complete genome sequence of the type strain C. argentoratense IBS B10697T (DSM 44202) comprises 2,031,902 bp, revealing so far the smallest sequenced genome of a corynebacterial species associated with humans (10). To attain additional genetic knowledge of this pathogen, particularly of clinically relevant antibiotic resistances, we sequenced the genomes of two unrelated clinical macrolide-resistant strains isolated from patients in the University Hospital of León, Spain. C. argentoratense strain CNM 463/05 was obtained in 2005 from a blood culture of a 3-year-old boy with upper respiratory tract infection, and strain CNM 601/08 was obtained in 2008 from a blood culture of an 85-year-old female with ischemic colitis. Both C. argentoratense isolates were routinely grown at 37°C on blood agar. Genomic DNA was purified by using the ChargeSwitch gDNA mini bacteria kit (Invitrogen). Genome data were obtained as previously described (11) using an Ion Torrent PGM platform. The reads were collected by the Torrent Suite software version 4.0. The MIRA program version 3.4.0 (http://www.chevreux.org/projects_mira.html) was used for de novo assembly of the two genomes. Both genome sequences were annotated using the RAST genome annotation server (12). Both C. argentoratense isolates showed similar genome sizes (approximately 2.02 Mbp) and similar numbers of protein-coding regions (approximately 1,900), with a slightly higher number (1.3%) in the genome of CNM 463/05. The draft genome sequences of both isolates revealed a high grade of similarity between them (>99.9%), as well as with the genome sequence of the type strain C. argentoratense DSM 44202 (>95.0%). BLAST was used for the search for antibiotic resistance genes in the Antibiotic Resistance Genes Database (13) and in published genome information of Corynebacterium strains. The antibiotic resistance gene erm(X) coding for macrolide-lincosamide-streptogramin B resistance was detected in the genome of both isolates and was allocated to a specific genomic region with 100% similarity to the composite transposable element Tn5432, initially found on the R-plasmid pTP10 of Corynebacterium striatum M82B (14, 15). This transposon is composed of two IS1249 sequences, the erm(X) gene, and the partial transposase gene tnpCX (14). Transposon Tn5432 is widely distributed in corynebacteria (1) and was also detected in bifidobacteria (16) and propionibacteria (17, 18), indicating that the horizontal transfer of erm(X) occurred between these actinobacterial phyla. Previous antimicrobial susceptibility assays demonstrated that erm(X) provides high resistance levels not only to erythromycin but also to azithromycin, josamycin, midecamycin, roxithromycin, spiramycin, tylosin, clindamycin, lincomycin, quinupristin, and pristinamycin IA (15, 17, 19). Resistance of clinical C. argentoratense isolates to these antimicrobials should be considered in the future when prescribing antibiotics for the treatment of infections with this commensal corynebacterium.

Nucleotide sequence accession numbers.

The whole-genome shotgun projects for the two C. argentoratense strains have been deposited in the GenBank database under the accession numbers JZEZ00000000 (CNM 463/05) and JZFA00000000 (CNM 601/08).
  18 in total

1.  Species identities and antimicrobial susceptibilities of corynebacteria isolated from various clinical sources.

Authors:  P Riegel; R Ruimy; R Christen; H Monteil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-08       Impact factor: 3.267

2.  Characteristics of rare or recently described corynebacterium species recovered from human clinical material in Canada.

Authors:  K A Bernard; C Munro; D Wiebe; E Ongsansoy
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Inducible macrolide resistance in Corynebacterium jeikeium.

Authors:  A E Rosato; B S Lee; K A Nash
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria.

Authors:  T S El-Mahdy; S Abdalla; R El-Domany; M S Mohamed; J I Ross; A M Snelling
Journal:  Anaerobe       Date:  2010-06-10       Impact factor: 3.331

5.  High-performance liquid chromatography of corynomycolic acids as a tool in identification of Corynebacterium species and related organisms.

Authors:  D De Briel; F Couderc; P Riegel; F Jehl; R Minck
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

6.  Microbiological and host features associated with corynebacteriosis in cancer patients: a five-year study.

Authors:  Cas Martins; Lmd Faria; Mc Souza; Tcf Camello; E Velasco; R Hirata; Lcs Thuler; Al Mattos-Guaraldi
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-09       Impact factor: 2.743

7.  Corynebacterium argentoratense sp. nov., from the human throat.

Authors:  P Riegel; R Ruimy; D De Briel; G Prevost; F Jehl; F Bimet; R Christen; H Monteil
Journal:  Int J Syst Bacteriol       Date:  1995-07

8.  Characterization of mucosal biofilms on human adenoid tissues.

Authors:  Romain E Kania; Gerda E M Lamers; Marcel J Vonk; Esmee Dorpmans; Joyce Struik; Patrice Tran Ba Huy; Pieter Hiemstra; Guido V Bloemberg; Jan J Grote
Journal:  Laryngoscope       Date:  2008-01       Impact factor: 3.325

9.  Resistance determinant erm(X) is borne by transposon Tn5432 in Bifidobacterium thermophilum and Bifidobacterium animalis subsp. lactis.

Authors:  Angela H A M van Hoek; Sigrid Mayrhofer; Konrad J Domig; Henk J M Aarts
Journal:  Int J Antimicrob Agents       Date:  2008-04-02       Impact factor: 5.283

10.  Whole-Genome Sequence of the Clinical Strain Corynebacterium argentoratense DSM 44202, Isolated from a Human Throat Specimen.

Authors:  Christina Bomholt; Alina Glaub; Kerstin Gravermann; Andreas Albersmeier; Karina Brinkrolf; Christian Rückert; Andreas Tauch
Journal:  Genome Announc       Date:  2013-10-03
View more
  2 in total

Review 1.  Taxonomy, Physiology, and Natural Products of Actinobacteria.

Authors:  Essaid Ait Barka; Parul Vatsa; Lisa Sanchez; Nathalie Gaveau-Vaillant; Cedric Jacquard; Jan P Meier-Kolthoff; Hans-Peter Klenk; Christophe Clément; Yder Ouhdouch; Gilles P van Wezel
Journal:  Microbiol Mol Biol Rev       Date:  2015-11-25       Impact factor: 11.056

2.  Phenotypic, molecular characterization, antimicrobial susceptibility and draft genome sequence of Corynebacterium argentoratense strains isolated from clinical samples.

Authors:  I Fernández-Natal; J A Sáez-Nieto; D Rodríguez-Lázaro; S Valdezate-Ramos; T Parras-Padilla; M J Medina; R H Rodríguez-Pollán; J Blom; A Tauch; F Soriano
Journal:  New Microbes New Infect       Date:  2016-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.